Department of Neuroradiology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Department of Neurology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Clin Neuroradiol. 2023 Jun;33(2):483-490. doi: 10.1007/s00062-022-01236-0. Epub 2022 Dec 2.
Endovascular stroke treatment (EST) is commonly performed for acute basilar artery occlusion (BAO). We aimed to identify the role of the exact location of BAO in patients receiving EST regarding the stroke etiology, recanalization success and prediction of favorable clinical outcome.
Retrospective analysis of 191 consecutive patients treated for BAO with EST from 01/2013 until 06/2021 in a tertiary stroke center. Groups were defined according to exact location of BAO in I: proximal third, II: middle third, III: distal third and IV: tip of the basilar artery. Univariate and multivariate analyses were performed for BAO location comparing stroke etiology, recanalization result and favorable clinical outcome according to mRS 0-3 90 days after stroke onset.
Occlusion sides types I-IV were evenly distributed (37, 36, 60 and 58 patients). Types I and II were more often associated with large artery atherosclerosis (50 vs. 10 patients, p < 0.001). Distal/tip occlusion (types III/IV) occurred mostly in cardiac embolism or embolic stroke of unknown source (89 vs. 12 in types I/II, p < 0.001). Occlusion site correlated with the underlying stroke etiology (AUC [Area under the curve] 0.89, p < 0.0001, OR [odds ratio] for embolism in type IV: 245). Recanalization rates were higher in patients with distal occlusions (type III/IV OR 3.76, CI [95% confidence interval] 1.51-9.53, p = 0.0076). The BAO site is not predicting favorable clinical outcome.
The exact basilar artery occlusion site in patients eligible for endovascular stroke treatment reflects the stroke etiology and is associated with differing recanalization success but does not predict favorable clinical outcome.
血管内卒中治疗(EST)常用于治疗急性基底动脉闭塞(BAO)。我们旨在确定接受 EST 治疗的患者中 BAO 的准确位置在卒中病因、再通成功率和预测良好临床结局方面的作用。
对 2013 年 1 月至 2021 年 6 月在一家三级卒中中心接受 EST 治疗的 191 例连续 BAO 患者进行回顾性分析。根据 BAO 的精确位置将患者分为四组:I 组:近段三分之一;II 组:中段三分之一;III 组:远段三分之一;IV 组:基底动脉顶端。对 BAO 位置进行单变量和多变量分析,比较根据 mRS 在卒中发病后 90 天 0-3 分的卒中病因、再通结果和良好的临床结局。
BAO 类型 I-IV 侧的分布均匀(37、36、60 和 58 例)。I 型和 II 型更多地与大动脉粥样硬化相关(50 例 vs. 10 例,p<0.001)。远段/顶端闭塞(III/IV 型)多发生于心源性栓塞或不明来源的栓塞性卒中(89 例 vs. I/II 型的 12 例,p<0.001)。闭塞部位与潜在的卒中病因相关(曲线下面积 [AUC] 0.89,p<0.0001,IV 型栓塞的比值比 [OR]:245)。远端闭塞患者的再通率更高(III/IV 型 OR 3.76,CI [95%置信区间] 1.51-9.53,p=0.0076)。BAO 部位并不能预测良好的临床结局。
接受血管内卒中治疗的患者的基底动脉闭塞的确切部位反映了卒中病因,并与不同的再通成功率相关,但不能预测良好的临床结局。